Vitamin D activation: promotes renal 1 - hydroxylase activity, accelerates the conversion of 25 (OH) D to active 1,25 (OH) D, and enhances the calcium absorption promoting effect of vitamin D
The federal health agency warns that taking these drugs could result in harmful effects, such as liver or kidney damage, blood clots, cancerous tumours, blood sugar and hormonal imbalance and mood swings
Regulatory & evidence callout: DSIP is investigational, research-only, and not FDA-approved
Animal-based studies have also reported that BPC-157 may mitigate drug-induced tissue stress, enhance microcirculatory dynamics, and reduce markers of oxidative damage
Tirzepatide holds FDA approvals as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (2024), and it is EMA-approved as well
Label your vials